Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1997
02/20/1997WO1997005894A1 Pharmaceutical composition containing il-10
02/20/1997WO1997005892A1 Use of betaglycan to reduce scarring
02/20/1997WO1997005883A1 Pharmaceutical composition
02/20/1997WO1997005881A1 Stable solid formulation of enalapril salt and process for preparation thereof
02/20/1997WO1997005880A1 Aqueous compositions containing ciprofloxacine, and related use and process
02/20/1997WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
02/20/1997WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
02/20/1997WO1997005876A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
02/20/1997WO1997005875A2 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
02/20/1997WO1997005874A1 Biotin-containing liquid preparation for internal use
02/20/1997WO1997005873A2 Use of fluconazole for inhibiting the growth of cancers
02/20/1997WO1997005872A2 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
02/20/1997WO1997005871A1 Nitric oxide synthase (nos) inhibitors
02/20/1997WO1997005870A2 Use of griseofulvin for inhibiting the growth of cancers
02/20/1997WO1997005869A1 Ibogamine congeners
02/20/1997WO1997005868A1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
02/20/1997WO1997005867A1 Treatment of trichomonal infections with ditiocarb or disulfiram
02/20/1997WO1997005866A1 Method and composition for preventing hair loss following chemotherapy
02/20/1997WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
02/20/1997WO1997005864A2 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
02/20/1997WO1997005863A1 Preventive or remedy for diseases caused by abnormalities in cartilage tissues
02/20/1997WO1997005862A2 Use of basic amino acids and derivatives for lowering ceramide levels
02/20/1997WO1997005861A1 Calcium-containing agent for intestinal phosphate binding and process for producing it
02/20/1997WO1997005860A1 Photostable aqueous solution containing benzyl alcohol derivatives
02/20/1997WO1997005859A2 Use of alicyclic diamines as immunomodulators
02/20/1997WO1997005858A1 Aerosol preparation
02/20/1997WO1997005856A1 Physically active antimicrobial gel for cosmetic products
02/20/1997WO1997005780A1 Regulation of alzheimer's disease related proteins and uses thereof
02/20/1997WO1997005771A2 Lysosomal proteins produced in the milk of transgenic animals
02/20/1997WO1997002821A3 Antifungal agent, compound therefor, process for producing the same
02/20/1997WO1997002810A3 Polymeric lamellar substrate particles for drug delivery
02/20/1997WO1997002730A3 Enamel matrix related polypeptide
02/20/1997WO1996040668A3 Small molecule inhibition of rna/ligand binding
02/20/1997WO1996039147A3 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
02/20/1997WO1996024345A3 Uses of a vitamin of the k-group against a loss of cognitive faculties
02/20/1997DE19531936A1 Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend Combination product for contraception, kits containing them and a method using these
02/20/1997DE19530884A1 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Infektionen Use of prostane derivatives and their combination with antibiotics to treat bacterial infections
02/20/1997CA2512366A1 Mammalian iap gene family, primers, probes and detection methods
02/20/1997CA2239616A1 Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer
02/20/1997CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
02/20/1997CA2229074A1 Nitric oxide synthase (nos) inhibitors
02/20/1997CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof
02/20/1997CA2229024A1 Use of fluconazole for inhibiting the growth of cancers
02/20/1997CA2228843A1 1- 2-(2,3-dihydro-1h-inden-1-yl)ethyl -4-(naphth-1-yl) piperazine derivatives, their preparation and their application in therapeutics
02/20/1997CA2228813A1 Medicament for inhibiting dependency and tolerance developed by narcoticanalgesic agent
02/20/1997CA2228689A1 Use of alicyclic diamines as immunomodulators
02/20/1997CA2228650A1 Use of betaglycan to reduce scarring
02/20/1997CA2228620A1 Treatment of ocular inflammatory conditions with interleukin-10
02/20/1997CA2228528A1 Novel penam sulfones as beta-lactamase inhibitors
02/20/1997CA2228513A1 Isomerisation process
02/20/1997CA2228503A1 Use of griseofulvin for inhibiting the growth of cancers
02/20/1997CA2228502A1 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
02/20/1997CA2228379A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
02/20/1997CA2228314A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
02/20/1997CA2228286A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
02/20/1997CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
02/20/1997CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
02/20/1997CA2227912A1 Benzenesulphonamide derivatives, their preparation and their application in therapy
02/20/1997CA2227584A1 Transgenic swine and swine cells having human hla genes
02/20/1997CA2227204A1 Human mp52 arg protein
02/20/1997CA2225647A1 Regulation of alzheimer's disease related proteins and uses thereof
02/20/1997CA2225553A1 Cell derived antigen presenting vesicles
02/20/1997CA2221729A1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
02/20/1997CA2221241A1 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
02/20/1997CA2213773A1 Imidazopyridine derivatives
02/19/1997EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
02/19/1997EP0758650A1 Endothelin receptor antagonists
02/19/1997EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels
02/19/1997EP0758647A1 Acyl substituted aminopyrans with a modulating effect on calcium channels
02/19/1997EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
02/19/1997EP0758548A1 Local anesthetics for topical treatment of back pain and muscle bracing
02/19/1997EP0758453A1 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
02/19/1997EP0758340A1 Process for the preparation of 4-amino-delta 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids
02/19/1997EP0758339A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives
02/19/1997EP0758335A1 Preparation of a camptothecin derivative by intramolecular cyclisation
02/19/1997EP0758333A1 Intermediates in pharmaceutical camptothecin preparation
02/19/1997EP0758331A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
02/19/1997EP0758330A1 Biphenylcarboxamides useful as 5-ht1d antagonists
02/19/1997EP0758329A1 Morpholine derivatives and their use as antagonists of tachikinins
02/19/1997EP0758328A1 Anti-cancer compounds containing cyclopentaquinazoline ring
02/19/1997EP0758327A1 Pyranone compounds useful to treat retroviral infections
02/19/1997EP0758314A1 Compounds containing a michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions
02/19/1997EP0758313A1 Combinatorial dihydrobenzopyran library
02/19/1997EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents
02/19/1997EP0758252A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS
02/19/1997EP0758250A1 Texaphyrin solid-supports and devices
02/19/1997EP0758247A1 O-desulfated heparin derivatives, methods of making and uses thereof
02/19/1997EP0758246A1 Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis
02/19/1997EP0758245A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
02/19/1997EP0758244A1 Controlled-release dosage forms of azithromycin
02/19/1997EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa
02/19/1997EP0758242A1 Composition and method for treatment of cmv infection
02/19/1997EP0758241A1 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
02/19/1997EP0758240A1 Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
02/19/1997EP0758239A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
02/19/1997EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists
02/19/1997EP0758237A1 Lactone stable formulation of camptothecin or 7-ethyl camptothecin
02/19/1997EP0758236A1 Human body weight management
02/19/1997EP0758235A1 Polymer coated tablet comprising amoxycillin and clavulanate
02/19/1997EP0758234A1 Method and composition for treating renal disease and failure